From a risk manager’s point of view, the pandemic could not have descended at a worse time. As the market was already “hard” (read: expensive) with reinsurers being selective in the risk profiles they would cover, the natural move into self-insurance, seemed logical. However, as many risk managers will share, setting up a pure single parent captive can be time consuming, hence the use of cell captives has seen an unprecedented surge globally.
Join us as we consider the Asian risk landscape, currently and post COVID-19 and how it may affect your risk mitigation strategies. This will be followed by a panel of industry experts and practitioners in self-insurance, who will discuss how cell captives may indeed be the solution towards developing a customised risk management programme.